Myocardial contractility after infarction and carnitine palmitoyltransferase I inhibition in rats

European Journal of Pharmacology

Volumn 406, Issue 1, 2000, Pages 123-126

  Günther, Joachim ^a   Wagner, Kay Dietrich ^a   Theres, Heinz ^a   Schimke, Ingolf ^a   Born, Annkathrin ^a   Scholz, Holger ^a   Vetter, Roland ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Inst Clin Pharmacol and Toxicol   (Germany)

Author keywords

Carnitine palmitoyltransferase I inhibition; Contractile function; Etomoxir; Heart; Hypertrophy; Infarct size; Rat

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; ETOMOXIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; CARNITINE O-PALMITOYLTRANSFERASE; ENZYME INHIBITORS; EPOXY COMPOUNDS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGAN SIZE; PAPILLARY MUSCLES; RATS; RATS, WISTAR;

EID: 0343777312     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00666-X     Document Type: Article

References (11)

1. Bers D. Ca transport during contraction and relaxation in mammalian ventricular muscle. Basic Res. Cardiol. 92((Suppl. 1)):1997;1-10.
2. Gülch R.W. Principles of assessment of cardiac mechanics. Jacob R. Evaluation of Cardiac Contractility. 1990;47-60 Gustav Fischer Verlag Stuttgart, New York.
3. Lammerich A., Günther J., Pfitzer G., Storch E., Vetter R. Alterations of cardiac contractile function are related to changes in membrane calcium transport in spontaneously hypertensive rats. J. Hypertens. 13:1995;1313-1324.
4. Mercadier J.J., Lompré A.M., Wisnewsky C., Samuel J.L., Bercovici J., Swinghedauw B., Schwartz K. Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ. Res. 49:1981;525-532.
5. Pfeffer M.A., Braunwald E., Moyé L.A., Basta L., Brown E.J., Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C., Klein M., Lamas G.A., Packer M., Rouleau J.L., Rutherford J., Wertheimer J.H., Hawkins C.M. Effect of captopril on mortality in morbidity in patients with left ventricular dysfunction after myocardial infarction: results of survival and ventricular enlargement trial. N. Engl. J. Med. 327:1992;669-677.
6. Rupp H., Elimban V., Dhalla N.S. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J. 6:1992;2349-2353.
7. Schmidt-Schweda S., Holubarsch C. First clinical trial with etomoxir in patients with chronic heart failure NYHA II-III. J. Mol. Cell. Cardiol. 29(A55):1997;. (Abstract).
8. Vetter R., Rupp H. CPT-1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isomyosins. Am. J. Physiol. 267:1994;H2091-H2099.
9. Wagner K.D., Theres H., Born A., Strube S., Wunderlich N., Pfitzer G., Baumann G., Günther J. Contractile function of papillary muscle from rats with different infarct size after β-adrenergic blockade and ACE-inhibition. J. Mol. Cell. Cardiol. 29:1997;2941-2951.
10. Wagner K.D., Geil D., Schimke I., Stauss H.M., Lammerich A., Theres H., Pfitzer G., Vetter R., Günther J. Decreased susceptibility of contractile function to hypoxia/reoxygenation in chronic infarcted rat hearts. J. Mol. Cell. Cardiol. 30:1998;2341-2353.
11. 2+-pump ATPase in congestive heart failure due to myocardial infarction. Mol. Cell. Biochem. 163-164:1996;285-290.